Frequently Asked Questions:
COVID-19 has had a substantial impact on the market due to the outbreak of the COVID-19 pandemic. The BCG vaccine market has seen some revenue. The BCG vaccine is utilized to prevent Tuberculosis (TB), but some researchers have announced that the BCG vaccine can be used for COVID treatment, fuelling the market.
Asia-Pacific accounted for the most heightened share in the global BCG vaccine market.
Increased prevalence of tuberculosis and increasing company initiatives to enhance vaccine R&D drive the global BCG vaccine market.
The pediatrics segment had a major share in the global market in 2022.
The tuberculosis segment had a major share in the global market.